Drug archive
Samarium Sm 153 Lexidronam (Therapeutic)
Archived drug information. This USP DI monograph is kept for reference and dates from the mid-2000s. Doses, warnings, interactions and brand names may have changed, and some products are no longer sold. Always follow your prescriber, your pharmacist and the current label, for example on DailyMed.
Category
- Antineoplastic
Description
Samarium Sm 153 lexidronam (sa-MARE-ee-um lex-ID-roe-nam) is a radiopharmaceutical ((ray-dee-oh-far-ma-SOO-ti-kal)) . Radiopharmaceuticals are radioactive agents that may be used to diagnose some diseases by studying the function of the body's organs or to treat certain diseases.
Samarium Sm 153 lexidronam is used to help relieve the bone pain that may occur with certain kinds of cancer. The radioactive samarium is taken up in the bone cancer area and gives off radiation that helps provide relief of pain.
Samarium Sm 153 lexidronam is to be given only by or under the direct supervision of a doctor with specialized training in nuclear medicine or radiation oncology. It is available in the following dosage form:
- Injection (U.S.)
Brand Names
Some commonly used brand names are:
In the U.S. -
- Quadramet
† Not commercially available in Canada.